Biogen Inc. (BIIB) was upgraded to a "buy" by TheStreet's Quant Ratings service on Wednesday. This biotech name has made a chart that could be challenging to many traders and investors. Let's drill down and see if an easier approach to the long side can be found.
More from Stocks
We're unlikely to see anything shake off this action during the dog days of summer.
Is the truth in the jobs report or GM's earnings? Or is it in the cruise lines or the real estate firms? Let me show you the 'REIT' way to look at it.
The psychedelics treatment area won't be a zero-sum game.
I'm considering an add Friday based on what I see on the weekly chart.
Here we look at furniture company Ethan Allen, which benefited from the pandemic, and cybersecurity name McAfee, which could profit from recent big hack attacks.